Read the First Edition of The Lens, a new magazine by LSI arrow-icon
Learn More About Juno Therapeutics
Juno Therapeutics
Reports Graph
Immunotherapy platforms to treat a variety of high-risk cancers: 1-Chimeric antigen receptors (CAR) technology that targets cell surface antigens that are expressed on cancer cells and 2-T cell receptors (TCR) technology that detects alterations in intracellular proteins present in tumor cells
Technology/product details
Revenue projections
Capital raised to date
Growth strategy
Competing Startups
More

Get a Demo and See the Full Profile

Get a demo today to see profiles of Spineology plus 6164 other startups.

Trusted By The Companies Pioneering What’s Next